Scientific Program at the Annual Meeting

In 2010, we look forward to broadening our scope and highlighting some grand achievements in neurology. This year we have an exciting new Awards Plenary Session to highlight the latest research honored through the AAN Awards Luncheon. Recipients of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases; the Sheila Essey Award—An Award for ALS Research; the John Dystel Prize for Multiple Sclerosis Research; and the Dreifuss-Penry Epilepsy Award will each take the stage to give a 30-minute presentation on the plenary stage. We look forward to bringing these researchers and their hard-won efforts to a wider audience. The Academy is also focusing on clinical patient issues in the new Friday Clinical Trials Session, which identifies key presentations from other conferences, provides an even broader context for the researcher presented at our Annual Meeting, and gives practitioners and researchers alike a better understanding of the current state of neurology.— Stefan M. Pulst, MD, FAAN

The AAN Annual Meeting brings together more than 10,000 neuroscience professionals for the world's largest neurology gathering. It has long been a leading showcase for the latest developments in scientific research, and a place to honor peers at the forefront of this work.

2010 Scientific Sessions at a Glance

Opportunities in Neuroscience

  • Plenary Sessions
    Six premier Plenary Sessions feature lectures by esteemed investigators discussing critical advances in neuroscience. New for 2010: Awards Plenary Session. Review a previous scientific presentation or plenary session from previous Annual Meetings in the Plenary Session history section.
  • Integrated Neuroscience Sessions
    These sessions present an expansive look at significant topics within the field of neuroscience. In 2010, there will be 10 sessions, up from the six featured in years past. The topics will include:
    • Current Concepts in Cognitive Neuroscience: Implications for Neurological Disease
    • Molecular Markers and Targets in Neuro-Oncology
    • Emerging Treatments in Neuromuscular Disease
    • Emerging Concepts in Genetics
    • Global Neurology: Toxins and Infections
    • Multiple Sclerosis Imaging
    • Deep Brain Stimulation: Where Are We and Where Do We Go From Here?
    • Proteins, Genes, Neurodegeneration, and the Clinical Presentations
    • Pediatric Demyelinating Disorders
    • Ischemic Stroke, Interventional, and Endovascular Therapies/Large Vessel Disease

For more information about the Scientific Program, please contact Kevin Heinz at kheinz@aan.com or (651) 695-2773.

Back to top.

AAN Annual Meeting Disclosure Information

In an effort to provide as much information to our attendees as possible, the Meeting Management Committee, with the support and approval of the Education and Science Committees, requires full disclosure of all individuals involved in the 61st Annual Meeting program, including platform session co-chairs, education programs directors and faculty members, science presenters, selected committee and subcommittee members, members of the AAN Board of Directors, and selected AAN staff. This information is kept on file, updated on an annual basis, and reviewed each time an individual contributes to an AAN program.

For More Information

For more information about the Scientific Program, please contact Kevin Heinz at kheinz@aan.com or (651) 695-2773

Back to top.

For More Information
Erin Jackson

Program Manager, Scientific Programs
(651) 695-2704
ejackson@aan.com